6.45

2.38% 0.15

After Hours: 6.54 0.09 +1.40%

Pulmonx Corp (LUNG)

Overview News Price History Option Chain Financials Discussions Forecast

Pulmonx Corp stock is traded at $6.45, with a volume of 46,941. It is up +2.38% in the last 24 hours and down -4.73% over the past month. Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Previous Close:

$6.30

Open:

$6.34

24h Volume:

46,941

Relative Volume:

0.21

Market Cap:

$254.70M

Revenue:

$68.68M

Net Income/Loss:

$-60.84M

P/E Ratio:

-4.0062

EPS:

-1.61

Net Cash Flow:

$-38.42M

1W Performance:

-5.01%

1M Performance:

-4.73%

6M Performance:

-14.34%

1Y Performance:

-41.52%

1-Day Range:

$6.29

$6.475

1-Week Range:

$6.26

$7.09

52-Week Range:

$5.46

$14.84

Pulmonx Corp Stock (LUNG) Company Profile

Name

Pulmonx Corp

Sector

Healthcare (1180)

Industry

Medical Devices (148)

Phone

650-364-0400

Address

700 CHESAPEAKE DRIVE, REDWOOD CITY

Employee

279

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LUNG's Discussions on Twitter

Compare LUNG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LUNG Pulmonx Corp	6.45	254.70M	68.68M	-60.84M	-38.42M	-1.60
ABT Abbott Laboratories	118.77	206.00B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	392.15	149.49B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.66	133.62B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	86.54	110.97B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	71.35	42.08B	6.60B	4.16B	490.10M	6.93

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-04-24	Initiated	Lake Street	Buy
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Sep-05-23	Initiated	Craig Hallum	Buy
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform
Dec-12-22	Upgrade	Citigroup	Neutral → Buy
Jul-11-22	Downgrade	Citigroup	Buy → Neutral
Mar-02-22	Resumed	BofA Securities	Neutral
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight
Apr-01-21	Initiated	Citigroup	Buy
Mar-25-21	Initiated	Piper Sandler	Neutral
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	BofA Securities	Buy
Oct-26-20	Initiated	Canaccord Genuity	Buy
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight
Oct-26-20	Initiated	Stifel	Buy
Oct-26-20	Initiated	Wells Fargo	Equal Weight

View All

Pulmonx Corp Stock (LUNG) Latest News

Nov 27, 2024

Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World

Nov 27, 2024

Nov 26, 2024

Pulmonx director French sells $132,600 in stock - Investing.com

Nov 26, 2024

Pulmonx director French sells $132,600 in stock By Investing.com - Investing.com UK

Nov 26, 2024

Millrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat

Nov 26, 2024

Nov 21, 2024

Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? - Yahoo Finance

Nov 21, 2024

Nov 20, 2024

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Yahoo Finance

Nov 19, 2024

Nov 13, 2024

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Yahoo Finance

Nov 07, 2024

Nov 05, 2024

Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know - Yahoo Finance

Nov 05, 2024

Nov 02, 2024

Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results - Yahoo Finance UK

Nov 02, 2024

Nov 01, 2024

Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 01, 2024

Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024

Oct 31, 2024